Bergamasco João G A, Scarpelli Maíra C, Godwin Joshua S, Mesquita Paulo H C, Chaves Talisson S, da Silva Deivid G, Bittencourt Diego, Dias Nathalia F, Medalha Ricardo A, Carello Filho Paulo C, Angleri Vitor, Costa Luiz A R, Michel J Max, Vechin Felipe C, Kavazis Andreas N, Ugrinowitsch Carlos, Roberts Michael D, Libardi Cleiton A
MUSCULAB-Laboratory of Neuromuscular Adaptations to Resistance Training, Department of Physical Education, Federal University of São Carlos (UFSCar), São Carlos, Brazil.
School of Kinesiology, Auburn University, Auburn, Alabama, United States.
J Appl Physiol (1985). 2024 Oct 1;137(4):910-918. doi: 10.1152/japplphysiol.00354.2024. Epub 2024 Aug 15.
The aim of this study was to investigate whether baseline values and acute and chronic changes in androgen receptors (AR) markers, including total AR, cytoplasmic (cAR), and nuclear (nAR) fractions, as well as DNA-binding activity (AR-DNA), are involved in muscle hypertrophy responsiveness by comparing young nonresponder and responder individuals. After 10 wk of resistance training (RT), participants were identified as nonresponders using two typical errors (TE) obtained through two muscle cross-sectional area (mCSA) ultrasound measurements (2 × TE; 4.94%), and the highest responders within our sample were numerically matched. Muscle biopsies were performed at baseline, 24 h after the first RT session (acute responses), and 96 h after the last session (chronic responses). AR, cAR, and nAR were analyzed using Western blotting, and AR-DNA was analyzed using an ELISA-oligonucleotide assay. Twelve participants were identified as nonresponders (ΔmCSA: -1.32%) and 12 as responders (ΔmCSA: 21.35%). There were no baseline differences between groups in mCSA, AR, cAR, nAR, or AR-DNA ( > 0.05). For acute responses, there was a significant difference between nonresponders (+19.5%) and responders (-14.4%) in AR-DNA [effect size (ES) = -1.39; 95% confidence interval (CI): -2.53 to -0.16; = 0.015]. There were no acute between-group differences in any other AR markers ( > 0.05). No significant differences between groups were observed in chronic responses across any AR markers ( > 0.05). Nonresponders and responders presented similar baseline, acute, and chronic results for the majority of the AR markers. Thus, our findings do not support the influence of AR markers on muscle hypertrophy responsiveness to RT in untrained individuals. We explored, for the first time, the influence of androgen receptor (AR) through the separation of cytoplasmic and nuclear cell fractions [i.e., cytoplasmic androgen receptor (cAR), nuclear androgen receptor (nAR), and androgen receptor DNA-binding activity (AR-DNA)] on muscle hypertrophy responsiveness to resistance training. The absence of muscle hypertrophy in naïve individuals does not seem to be explained by baseline values, and acute or chronic changes in AR markers.
本研究旨在通过比较年轻的无反应者和有反应者个体,探讨雄激素受体(AR)标志物的基线值以及急性和慢性变化,包括总AR、细胞质(cAR)和细胞核(nAR)组分,以及DNA结合活性(AR-DNA)是否与肌肉肥大反应性有关。在进行10周的抗阻训练(RT)后,通过两次肌肉横截面积(mCSA)超声测量获得的两个典型误差(TE)(2×TE;4.94%)将参与者确定为无反应者,并在我们的样本中对最高反应者进行数值匹配。在基线、第一次RT训练后24小时(急性反应)和最后一次训练后96小时(慢性反应)进行肌肉活检。使用蛋白质免疫印迹法分析AR、cAR和nAR,使用酶联免疫吸附测定-寡核苷酸分析法分析AR-DNA。12名参与者被确定为无反应者(ΔmCSA:-1.32%),12名参与者被确定为有反应者(ΔmCSA:21.35%)。两组在mCSA、AR、cAR、nAR或AR-DNA的基线值上无差异(P>0.05)。对于急性反应,无反应者(+19.5%)和有反应者(-14.4%)在AR-DNA方面存在显著差异[效应大小(ES)=-1.39;95%置信区间(CI):-2.53至-0.16;P=0.015]。在任何其他AR标志物的急性组间差异均无统计学意义(P>0.05)。在任何AR标志物的慢性反应中,未观察到组间有显著差异(P>0.05)。无反应者和有反应者在大多数AR标志物的基线、急性和慢性结果方面相似。因此,我们的研究结果不支持AR标志物对未经训练个体的肌肉肥大对RT反应性的影响。我们首次通过分离细胞质和细胞核细胞组分[即细胞质雄激素受体(cAR)、细胞核雄激素受体(nAR)和雄激素受体DNA结合活性(AR-DNA)]探讨了雄激素受体(AR)对肌肉肥大对抗阻训练反应性的影响。未经训练个体中缺乏肌肉肥大似乎不能用基线值以及AR标志物的急性或慢性变化来解释。